Silvant Capital Management LLC Takes Position in Celsius Holdings, Inc. (NASDAQ:CELH)

Silvant Capital Management LLC purchased a new stake in shares of Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 38,605 shares of the company's stock, valued at approximately $2,105,000.

Several other institutional investors and hedge funds have also made changes to their positions in CELH. Cary Street Partners Investment Advisory LLC increased its position in Celsius by 1,350.0% in the third quarter. Cary Street Partners Investment Advisory LLC now owns 145 shares of the company's stock worth $25,000 after buying an additional 135 shares during the period. Heritage Wealth Advisors acquired a new stake in Celsius in the third quarter worth $32,000. St. Johns Investment Management Company LLC acquired a new stake in Celsius in the third quarter worth $34,000. Parkside Financial Bank & Trust acquired a new stake in Celsius in the second quarter worth $30,000. Finally, Harvest Fund Management Co. Ltd acquired a new stake in Celsius in the third quarter worth $36,000. 60.95% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Celsius

In related news, Director Caroline S. Levy sold 20,000 shares of the stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $94.77, for a total value of $1,895,400.00. Following the completion of the sale, the director now directly owns 37,891 shares of the company's stock, valued at approximately $3,590,930.07. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, Director Nicholas Castaldo sold 165,000 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $83.33, for a total value of $13,749,450.00. Following the completion of the sale, the director now directly owns 352,864 shares of the company's stock, valued at approximately $29,404,157.12. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Caroline S. Levy sold 20,000 shares of the stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $94.77, for a total value of $1,895,400.00. Following the completion of the sale, the director now directly owns 37,891 shares of the company's stock, valued at $3,590,930.07. The disclosure for this sale can be found here. Insiders sold 1,094,783 shares of company stock worth $62,679,671 in the last quarter. 2.70% of the stock is owned by company insiders.

Celsius Stock Performance

Shares of NASDAQ:CELH traded up $4.47 during midday trading on Friday, reaching $83.94. The company had a trading volume of 4,246,807 shares, compared to its average volume of 3,681,371. Celsius Holdings, Inc. has a 1-year low of $28.08 and a 1-year high of $99.62. The firm has a market cap of $19.39 billion, a price-to-earnings ratio of 108.54, a price-to-earnings-growth ratio of 2.45 and a beta of 1.86. The company has a fifty day simple moving average of $74.24 and a two-hundred day simple moving average of $62.84.

Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings results on Thursday, February 29th. The company reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The business had revenue of $347.44 million during the quarter, compared to analyst estimates of $326.77 million. During the same quarter last year, the company posted $0.01 EPS. Celsius's revenue for the quarter was up 95.2% on a year-over-year basis. Analysts expect that Celsius Holdings, Inc. will post 1.09 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CELH. Stifel Nicolaus increased their price target on Celsius from $67.00 to $90.00 and gave the stock a "buy" rating in a research note on Friday, March 1st. Bank of America cut Celsius from a "buy" rating to a "neutral" rating and set a $65.00 price target for the company. in a research note on Friday, January 19th. Morgan Stanley reissued an "equal weight" rating and issued a $75.00 price target on shares of Celsius in a research note on Wednesday, March 27th. UBS Group increased their price target on Celsius from $73.00 to $99.00 and gave the stock a "buy" rating in a research note on Friday, March 1st. Finally, Jefferies Financial Group increased their price target on Celsius from $98.00 to $105.00 and gave the stock a "buy" rating in a research note on Monday, March 18th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $85.10.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.